American Journal of Obstetrics & Gynecology
Volume 200, Issue 4 , Pages 395.e1-395.e9 , April 2009

A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women

Presented at the 54th Annual Meeting of the Society for Gynecologic Investigation, Reno, NV, March 14-17, 2007.

Received 22 May 2008 ,Revised 28 August 2008 ,Accepted 13 October 2008.

References 

  1. Hedley AA, Ogden CL, Johnson CL, Carrolle MD, Curtin LR, Flegal KM. Prevalence of overweight and obesity among US children, adolescents and adults, 1999–2002. JAMA. 2004;291:2847–2850
  2. Government Office for Science. Foresight (Tackling obesities: future choices–project report 2007). www.foresight.gov.ukAccessed July 1, 2007.
  3. Kanalingam MG, Forouhi NG, Greer IA, Sattar N. Changes in booking body mass index over a decade: retrospective analysis from a Glasgow Maternity Hospital. BJOG. 2005;112:1431–1433
  4. Heslehurst N, Ellis LJ, Simpson H, Batterham A, Wilkinson J, Summerbell CD. Trends in maternal obesity incidence rates, demographic predictors and health inequalities in 36,821 women over a 15-year period. BJOG. 2007;114:187–194
  5. Yu CK, Teoh TG, Robinson S. Obesity in pregnancy. BJOG. 2006;113:1117–1125
  6. Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565
  7. Villamor E, Cnattingius S. Interpregnancy weight change and risk of adverse pregnancy outcomes: a population-based study. Lancet. 2006;368:1164–1170
  8. Catalano PM, Kirwan JP, Haugel-de Mouzon S, King J. Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus. J Nutr. 2003;133:1674S-83.
  9. Hillier TA, Pedula KL, Schmidt MM, Mullen JA, Charles MA, Pettitt DJ. Childhood obesity and metabolic imprinting: the outgoing effects of maternal hyperglycemia. Diabetes Care. 2007;30:2287–2292
  10. Gillman MW, Rifas-Shiman SL, Kleinman K, Oken E, Rich-Edwards JW, Taveras EM. Developmental origins of childhood overweight: potential public health impact. Obesity. 2008;16:1651–1656
  11. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomized placebo-controlled trial. Lancet. 2006;367:1145–1154
  12. Chappell LC, Enye S, Seed P, Briley AL, Poston L, Shennan AH. Adverse perinatal outcomes and risk factors for pre-eclampsia in women with chronic hypertension: a prospective study. Hypertension. 2008;51:1002–1009
  13. Ramsay JE, Ferrell WR, Crawford L, Wallace AM, Greer IA, Sattar N. Maternal obesity is associated with dysregulation of metabolic, vascular and inflammatory pathways. J Clin Endocrinol Metab. 2002;87:4231–4237
  14. Brown MA, Lindheimer MD, de Swiet M, Van Assche A, Moutquin JM. The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy. 2001;20:15–24
  15. Gardosi J, Chang A, Kalyan B, Sahota D, Symonds EM. Customized antenatal growth charts. Lancet. 1992;339:283–287
  16. Kelly FJ, Rodgers W, Handel J, Smith S, Hall MA. Time course of vitamin E repletion in the premature infant. Br J Nutr. 1990;63:631–638
  17. Iriyama K, Yoshiura M, Iwamoto T, Ozali Y. Simultaneous determination of uric and ascorbic acids in human serum by reversed-phase high-performance liquid chromatography with electrochemical detection. Anal Biochem. 1984;141:238–243
  18. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18:499–502
  19. Sim AS, Salonikas C, Naidoo D, Wilcken DE. Improved method for plasma malondialdehyde measurement by high-performance liquid chromatography using methyl malondialdehyde as an internal standard. J Chromatogr B Analyt Technol Biomed Life Sci. 2003;785:337–344
  20. Huber C, Hunsaker DM, Hunsaker JC. The relationship between elevated body mass index and lethal ischemic heart disease: an eleven-year retrospective review of medical examiners' adult autopsies in Kentucky. J Ky Med Assoc. 2005;103:93–101
  21. Sterne JA, Davey Smith G. Sifting the evidence–what's wrong with significance tests?. BMJ. 2001;322:226–231
  22. Cnattingius S, Bergstrom R, Lipworth L, Kramer MS. Prepregnancy weight and the risk of adverse pregnancy outcomes. N Engl J Med. 1998;338:147–152
  23. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103:219–224
  24. Bodnar LM, Catov JM, Klebanoff MA, Ness RB, Roberts JM. Prepregnancy body mass index and the occurrence of severe hypertensive disorders of pregnancy. Epidemiology. 2007;18:234–239
  25. Sibai BM, Ewell M, Levine RJ, et al. Risk factors associated with preeclampsia in healthy nulliparous women: the calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynecol. 1997;177:1003–1010
  26. Smith GC, Shah I, Pell JP, Crossley JA, Dobbie R. Maternal obesity in early pregnancy and risk of spontaneous and elective preterm deliveries: a retrospective cohort study. Am J Public Health. 2007;97:157–162
  27. Nohr EA, Bech BH, Vaeth M, Rasmussen KM, Henriksen TB, Olsen J. Obesity, gestational weight gain and preterm birth: a study within the Danish national birth cohort. Paediatr Perinat Epidemiol. 2007;21:5–14
  28. Groom KM, Poppe KK, North RA, McCowan LM. Small-for-gestational-age infants classified by customized or population birthweight centiles: impact of gestational age at delivery. Am J Obstet Gynecol. 2007;197:239.e1–239.e5
  29. Sebire NJ, Jolly M, Harris JP, et al. Maternal obesity and pregnancy outcome: a study of 287,213 pregnancies in London. Int J Obes Relat Metab Disord. 2001;25:1175–1182
  30. Office of National Statistics, Births, perinatal and infant mortality statistics, 2004: health statistics quarterly 27. http://www.statistics.gov.uk/STATBASE/Expodata/Spreadsheets/D9078.xlsAccessed July 1, 2007.
  31. Gluckman PD, Hanson MA. Maternal constraint of fetal growth and its consequences. Semin Fetal Neonatal Med. 2004;9:419–425
  32. Hendler I, Goldenberg RL, Mercer BM, et al. The preterm prediction study: association between maternal body mass index and spontaneous and indicated preterm birth. Am J Obstet Gynecol. 2005;192:882–886
  33. Baeten JM, Bukusi EA, Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women. Am J Public Health. 2001;91:436–440
  34. Saxena S. National Sentinel Caesarean Section audit. Int J Obs Anaes. 2001;11:270–274
  35. NPEU, recorded delivery: a national survey of women's experience of maternity care (National Perinatal Epidemiological Unit). Oxford, UK: University of Oxford Press; 2006;
  36. Galtier-Dereure F, Boegner C, Bringer J. Obesity and pregnancy: complications and cost. Am J Clin Nutr. 2000;71:1242-8S.
  37. Chu SY, Bachman DJ, Callaghan WM, et al. Association between obesity during pregnancy and increased use of health care. N Engl J Med. 2008;358:1444–1453
  38. Chappell LC, Seed PT, Briley A, et al. A longitudinal study of biochemical variables in women at risk of preeclampsia. Am J Obstet Gynecol. 2002;187:127–136
  39. Lippi G, Montagnana M, Franchini M, Favaloro EJ, Targher G. The paradoxical relationship between serum uric acid and cardiovascular disease. Clin Chim Acta. 2008;392:1–7
  40. Cnossen JS, de Ruyter-Hanhijarvi H, van der Post JA, Mol BW, Khan KS, ter Riet G. Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review. Acta Obstet Gynecol Scand. 2006;85:519–525
  41. Raijmakers MT, Peters WH, Steegers EA, Poston L. Amino thiols, detoxification and oxidative stress in pre-eclampsia and other disorders of pregnancy. Curr Pharm Des. 2005;11:711–734
  42. Raijmakers MT, Dechend R, Poston L. Oxidative stress and preeclampsia: rationale for antioxidant clinical trials. Hypertension. 2004;44:374–380
  43. Onat A, Uyarel H, Hergenc G, et al. Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens. 2006;19:1055–1062
  44. Lin JD, Chiou WK, Chang HY, Liu FH, Weng HF. Serum uric acid and leptin levels in metabolic syndrome: a quandary over the role of uric acid. Metabolism. 2007;56:751–756
  45. Bates CJ, Mishra GD, Prentice A. Gamma-tocopherol as a possible marker for nutrition-related risk: results from four national diet and nutrition surveys in Britain. Br J Nutr. 2004;92:137–150
  46. Ray JG, Diamond P, Singh G, Bell CM. Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG. 2006;113:379–386
  47. Sattar N, Greer IA, Louden J, et al. Lipoprotein subfraction changes in normal pregnancy: threshold effect of plasma triglyceride on appearance of small, dense low density lipoprotein. J Clin Endocrinol Metab. 1997;82:2483–2491

 Cite this article as: Rajasingam D, Seed PT, Briley AL, et al. A prospective study of pregnancy outcome and biomarkers of oxidative stress in nulliparous obese women. Am J Obstet Gynecol 2009;200:395.e1-395.e9.

 This study was supported by the Wellcome Trust (Grant no. 069056/Z/02/Z). L.P. and A.L.B. are funded by Tommy's the Baby Charity and by the National Institute for Health Research (NIHR) comprehensive Biomedical Research Center at Guy's & St. Thomas' National Health Service Foundation Trust in partnership with King's College London.

PII: S0002-9378(08)02070-X

doi: 10.1016/j.ajog.2008.10.047

American Journal of Obstetrics & Gynecology
Volume 200, Issue 4 , Pages 395.e1-395.e9 , April 2009

Article Tools

* Image Usage & Resolution